p.1 抽出テキスト

September 10, 2019 Circulation. 2019;140:e596–e646. DOI: 10.1161/CIR.0000000000000678 e596

*ACC/AHA Representative. †Lay Representative. ‡ACC/AHA Task Force on Clinical Practice Guidelines Liaison. §Task Force Performance Measures Representative. The American Heart Association requests that this document be cited as follows: Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. DOI: 10.1161/ CIR.0000000000000678

WRITING COMMITTEE MEMBERS Donna K. Arnett, PhD, MSPH, FAHA, Co-Chair Roger S. Blumenthal, MD, FACC, FAHA, Co-Chair Michelle A. Albert, MD, MPH, FAHA* Andrew B. Buroker, Esq† Zachary D. Goldberger, MD, MS, FACC, FAHA‡ Ellen J. Hahn, PhD, RN* Cheryl Dennison Himmelfarb, PhD, RN, ANP, FAHA* Amit Khera, MD, MSc, FACC, FAHA* Donald Lloyd-Jones, MD, SCM, FACC, FAHA* J. William McEvoy, MBBCh, MEd, MHS* Erin D. Michos, MD, MHS, FACC, FAHA* Michael D. Miedema, MD, MPH* Daniel Muñoz, MD, MPA, FACC* Sidney C. Smith Jr, MD, MACC, FAHA* Salim S. Virani, MD, PhD, FACC, FAHA* Kim A. Williams Sr, MD, MACC, FAHA* Joseph Yeboah, MD, MS, FACC, FAHA* Boback Ziaeian, MD, PhD, FACC, FAHA§

© 2019 by the American College of Cardiology Foundation and the American Heart Association, Inc.

ACC/AHA CLINICAL PRACTICE GUIDELINE

2019 ACC/AHA Guideline on the Primary

Prevention of Cardiovascular Disease

A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Circulation

https://www.ahajournals.org/journal/circ

ACC/AHA Task Force Members, see page e623

Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Geriatrics Society, the American Society of Preventive Cardiology, and the Preventive Cardiovascular Nurses Association

Key Words:  AHA Scientific Statements ◼ guidelines ◼ antihypertensive agents ◼ aspirin ◼ atherosclerosis ◼ atherosclerotic cardiovascular disease ◼ atrial fibrillation ◼ behavior modification ◼ behavior therapy ◼ blood cholesterol ◼ blood pressure ◼ body mass index ◼ cardiovascular team-based care ◼ cardiovascular ◼ cardiovascular disease ◼ cholesterol ◼ chronic kidney disease ◼ coronary artery calcium score ◼ coronary disease ◼ coronary heart disease ◼ cost ◼ diet ◼ dietary patterns ◼ dietary fats ◼ dietary sodium ◼ dyslipidemia ◼ e-cigarettes ◼ exercise ◼ healthcare disparities ◼ health services accessibility ◼ heart failure ◼ hypertension ◼ LDL cholesterol ◼ diabetes mellitus ◼ lifestyle ◼ lipids ◼ measurement ◼ myocardial infarction ◼ nicotine ◼ nonpharmacological treatment ◼ nutrition ◼ physical activity ◼ prejudice ◼ primary prevention ◼ psychosocial deprivation ◼ public health ◼ quality indicators ◼ quality measurement ◼ risk assessment ◼ risk-enhancing factors ◼ risk factors ◼ risk reduction ◼ risk reduction discussion ◼ risk treatment discussion ◼ secondhand smoke ◼ sleep ◼ smoking ◼ smoking cessation ◼ social determinants of health ◼ socioeconomic factors ◼ statin therapy ◼ systems of care ◼ tobacco ◼ tobacco smoke pollution ◼ treatment adherence ◼ treatment outcomes ◼ type 2 diabetes mellitus ◼ waist circumference ◼ weight loss

Downloaded from http://ahajournals.org by on October 7, 2026